Literature DB >> 7994169

The head and neck discomfort of autonomic failure: an unrecognized aetiology of headache.

D Robertson1, D W Kincaid, V Haile, R M Robertson.   

Abstract

Information concerning the frequency, severity, character, location, duration, diurnal pattern of headache and ancillary symptoms were obtained in 25 patients with autonomic failure and 44 control subjects. Precipitating and ameliorating factors were identified. Autonomic failure patients had more head and neck discomfort than controls. Their discomfort was much more likely to localize in the occiput, nape of the neck and shoulder, compared with controls. There was a greater tendency for the discomfort to occur in the morning and after meals. It was sometimes less than 5 min in duration and was often associated with dimming, blurring, or tunnelling of vision. It was provoked by upright posture and relieved by lying down. Patients with severe autonomic failure and orthostatic hypotension often present with a posture-dependent headache or neck pain. Because the relationship of these symptoms to posture is often not recognized, the fact that these findings may signal an underlying autonomic disorder is underappreciated, and the opportunity to consider this aetiology for the headache may be missed.

Entities:  

Keywords:  NASA Discipline Regulatory Physiology; Non-NASA Center

Mesh:

Year:  1994        PMID: 7994169     DOI: 10.1007/BF01845772

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  42 in total

1.  The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure.

Authors:  C J Mathias; P Fosbraey; D F da Costa; A Thornley; R Bannister
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-09

2.  Calcitonin gene-related peptide: functional role in cerebrovascular regulation.

Authors:  J McCulloch; R Uddman; T A Kingman; L Edvinsson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

3.  Volume expansion and vasodilators in the treatment of idiopathic postural hypotension.

Authors:  D H Jones; J L Reid
Journal:  Postgrad Med J       Date:  1980-04       Impact factor: 2.401

Review 4.  Headache. Public health problem.

Authors:  D K Ziegler
Journal:  Neurol Clin       Date:  1990-11       Impact factor: 3.806

5.  Pharmacologic distinction of different orthostatic hypotension syndromes.

Authors:  R J Polinsky; I J Kopin; M H Ebert; V Weise
Journal:  Neurology       Date:  1981-01       Impact factor: 9.910

6.  Clonidine raises blood pressure in severe idiopathic orthostatic hypotension.

Authors:  D Robertson; M R Goldberg; A S Hollister; D Wade; R M Robertson
Journal:  Am J Med       Date:  1983-02       Impact factor: 4.965

7.  Midodrine. A new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome.

Authors:  A Schirger; S G Sheps; J E Thomas; R D Fealey
Journal:  Mayo Clin Proc       Date:  1981-07       Impact factor: 7.616

8.  An epidemiologic study of headache among adolescents and young adults.

Authors:  M S Linet; W F Stewart; D D Celentano; D Ziegler; M Sprecher
Journal:  JAMA       Date:  1989-04-21       Impact factor: 56.272

9.  Comparative assessment of stimuli that release neuronal and adrenomedullary catecholamines in man.

Authors:  D Robertson; G A Johnson; R M Robertson; A S Nies; D G Shand; J A Oates
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

10.  The diagnosis and treatment of baroreflex failure.

Authors:  D Robertson; A S Hollister; I Biaggioni; J L Netterville; R Mosqueda-Garcia; R M Robertson
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

View more
  12 in total

Review 1.  New trends in the treatment of orthostatic hypotension.

Authors:  J Jordan
Journal:  Curr Hypertens Rep       Date:  2001-06       Impact factor: 5.369

Review 2.  Orthostatic hypotension: managing a difficult problem.

Authors:  Pearl K Jones; Brett H Shaw; Satish R Raj
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-10-01

3.  Orthostatic dyspnea: a neglected symptom of orthostatic hypotension.

Authors:  Christopher H Gibbons; Roy Freeman
Journal:  Clin Auton Res       Date:  2005-02       Impact factor: 4.435

Review 4.  Headache and Autonomic Dysfunction: a Review.

Authors:  Courtney Iser; Karissa Arca
Journal:  Curr Neurol Neurosci Rep       Date:  2022-08-22       Impact factor: 6.030

Review 5.  Syncope and Headache.

Authors:  Ramesh K Khurana
Journal:  Curr Pain Headache Rep       Date:  2018-06-15

6.  Influence of age and gender on the occurrence and presentation of reflex syncope.

Authors:  Jacobus J C M Romme; Nynke van Dijk; Kimberly R Boer; Lukas R C Dekker; Jan Stam; Johannes B Reitsma; Wouter Wieling
Journal:  Clin Auton Res       Date:  2008-04-30       Impact factor: 4.435

7.  Neck and other muscle pains in autonomic failure: their association with orthostatic hypotension.

Authors:  K M Bleasdale-Barr; C J Mathias
Journal:  J R Soc Med       Date:  1998-07       Impact factor: 5.344

Review 8.  Hemodynamic orthostatic dizziness/vertigo: Diagnostic criteria.

Authors:  Hyun Ah Kim; Alexandre Bisdorff; Adolfo M Bronstein; Thomas Lempert; Marcos Rossi-Izquierdo; Jeffrey P Staab; Michael Strupp; Ji-Soo Kim
Journal:  J Vestib Res       Date:  2019       Impact factor: 2.354

Review 9.  The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension.

Authors:  Christopher H Gibbons; Peter Schmidt; Italo Biaggioni; Camille Frazier-Mills; Roy Freeman; Stuart Isaacson; Beverly Karabin; Louis Kuritzky; Mark Lew; Phillip Low; Ali Mehdirad; Satish R Raj; Steven Vernino; Horacio Kaufmann
Journal:  J Neurol       Date:  2017-01-03       Impact factor: 4.849

Review 10.  Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management.

Authors:  Manuela Metzler; Susanne Duerr; Roberta Granata; Florian Krismer; David Robertson; Gregor K Wenning
Journal:  J Neurol       Date:  2012-11-20       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.